Ghrelin: from discovery to cancer cachexia therapy.

RPEP-024472014RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Ghrelin: from discovery to cancer cachexia therapy.
Published In:
Current opinion in clinical nutrition and metabolic care, 17(5), 471-6 (2014)
Database ID:
RPEP-02447

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-02447·https://rethinkpeptides.com/research/RPEP-02447

APA

Molfino, Alessio; Formiconi, Alessandra; Rossi Fanelli, Filippo; Muscaritoli, Maurizio. (2014). Ghrelin: from discovery to cancer cachexia therapy.. Current opinion in clinical nutrition and metabolic care, 17(5), 471-6. https://doi.org/10.1097/MCO.0000000000000075

MLA

Molfino, Alessio, et al. "Ghrelin: from discovery to cancer cachexia therapy.." Current opinion in clinical nutrition and metabolic care, 2014. https://doi.org/10.1097/MCO.0000000000000075

RethinkPeptides

RethinkPeptides Research Database. "Ghrelin: from discovery to cancer cachexia therapy." RPEP-02447. Retrieved from https://rethinkpeptides.com/research/molfino-2014-ghrelin-from-discovery-to

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.